Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity
Purpose: The authors report three separate cases of type 1 retinopathy of prematurity (ROP) treated with intravitreal bevacizumab before, or at 34 weeks postmenstrual age (PMA), with subsequent development of secondary glaucoma. Observations: All three cases involve patients born ≤24 weeks and meeti...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2024-12-01
|
| Col·lecció: | American Journal of Ophthalmology Case Reports |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2451993624001415 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|